MA-DL6K6-23
General Information
DRACP ID DRACP01756
Peptide Name MA-DL6K6-23
Sequence lKKllKKllKKl
Sequence Length 12
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
22Rv1 | Prostate carcinoma | Carcinoma | LC50<3.125 µM | MTT assay | Not available | Patent |
CL1 | Prostate carcinoma | Carcinoma | LC50<3.125 µM | MTT assay | Not available | Patent |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity NIH 3T3: LC50=50 μM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antimicrobial; Antifungal
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification CH3(CH2)12CO, Myristic acid
C-terminal Modification Amidation
Other Modification l=D-Leucine
Chiral Mix
Physicochemical Information
Formula C36H62N12O
Absent amino acids ACDEFGHILMNPQRSTVWY
Common amino acids K
Mass 87534
Pl 11.5
Basic residues 6
Acidic residues 0
Hydrophobic residues 0
Net charge 6
Boman Index -3330
Hydrophobicity -195
Aliphatic Index 0
Half Life
/
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US2007/0072808A1
Patent Title Antimicrobial and anticancer lipopeptides
Other Iinformation Patent Application; Family: 11s / 13ex; Family Jurisdictions: EP, US, AU, WO, CA; Legal Status: Active; Application No: 56072704; Filed: Jun 18, 2004; Published: Mar 29, 2007; Earliest Priority: Jun 19, 2003; Granted: Mar 2, 2010
Other Published ID AU2004246909A1 AU2004246909B2 CA2529125A1 EP1633380A2 EP1633380A4 US2010160213A1 US7671011B2 US8445636B2 WO2004110341A2 WO2004110341A3